Emergent BioSolutions Inc (EBS)
11.00
+1.80
(+19.57%)
USD |
NYSE |
Nov 07, 16:00
11.18
+0.18
(+1.64%)
Pre-Market: 05:48
Emergent BioSolutions Revenue (TTM): 1.074B for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.074B |
| March 31, 2024 | 1.158B |
| December 31, 2023 | 1.023B |
| September 30, 2023 | 1.076B |
| June 30, 2023 | 1.035B |
| March 31, 2023 | 938.80M |
| December 31, 2022 | 1.079B |
| September 30, 2022 | 1.389B |
| June 30, 2022 | 1.479B |
| March 31, 2022 | 1.616B |
| December 31, 2021 | 1.639B |
| September 30, 2021 | 1.568B |
| June 30, 2021 | 1.615B |
| March 31, 2021 | 1.614B |
| December 31, 2020 | 1.462B |
| September 30, 2020 | 1.236B |
| June 30, 2020 | 1.153B |
| March 31, 2020 | 984.50M |
| December 31, 2019 | 983.50M |
| September 30, 2019 | 891.60M |
| June 30, 2019 | 770.80M |
| March 31, 2019 | 772.30M |
| December 31, 2018 | 705.30M |
| September 30, 2018 | 638.82M |
| June 30, 2018 | 616.63M |
| Date | Value |
|---|---|
| March 31, 2018 | 492.70M |
| December 31, 2017 | 490.40M |
| September 30, 2017 | 416.74M |
| June 30, 2017 | 394.94M |
| March 31, 2017 | 373.66M |
| December 31, 2016 | 345.40M |
| September 30, 2016 | 376.17M |
| June 30, 2016 | 393.61M |
| March 31, 2016 | 426.01M |
| December 31, 2015 | 385.20M |
| September 30, 2015 | 343.22M |
| June 30, 2015 | 308.26M |
| March 31, 2015 | 304.83M |
| December 31, 2014 | 312.79M |
| September 30, 2014 | 305.51M |
| June 30, 2014 | 287.92M |
| March 31, 2014 | 266.06M |
| December 31, 2013 | 257.92M |
| September 30, 2013 | 246.60M |
| June 30, 2013 | 224.32M |
| March 31, 2013 | 211.88M |
| December 31, 2012 | 215.88M |
| September 30, 2012 | 178.50M |
| June 30, 2012 | 183.25M |
| March 31, 2012 | 218.23M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
938.80M
Minimum
Mar 2023
1.639B
Maximum
Dec 2021
1.270B
Average
1.158B
Median
Mar 2024
Revenue (TTM) Benchmarks
| Geovax Labs Inc | -- |
| Tonix Pharmaceuticals Holding Corp | 12.46M |
| Abbott Laboratories | 41.22B |
| SIGA Technologies Inc | 172.96M |
| Chimerix Inc | -- |